11/18/2026 | Press release | Distributed by Public on 11/18/2026 08:30
ABINGDON, Va. - The sentencing hearing for Bryce Cleveland, the former President and CEO of Scalpa, is set for April 9, 2027, at 11:00 a.m. before Judge Robert S. Ballou in U.S. District Court in Abingdon.
Scalpa pled guilty in July 2026 to three charges related to Scalpa's selling of skincare products that had not been approved by the U.S. Food and Drug Administration (FDA).
Scalpa was a for-profit corporation incorporated in Arizona in 2015 that marketed and sold medical devices and drug products intended to affect the structure and function of the human body. These products included ScalpaJECT Hyaluronic Acid, Hyaluron Pen, and Scalpatox.
Between 2018 and December 2020, Cleveland devised a fraudulent scheme to unlawfully enrich himself by marketing and delivering, and causing others to market and deliver, unapproved devices to customers, including ScalpaJECT Hyaluronic Acid and Hyaluron Pen, while making false representations that the devices were not subject to FDA regulation. Similarly, Cleveland introduced and delivered, and caused others to introduce and deliver, the unapproved drug "Scalpatox" into commerce.
If you believe you are a victim of any of the crimes charged, please find more information at https://www.justice.gov/criminal/criminal-vns/case/united-states-v-bryce-cleveland.